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Abstract
A gastrointestinal stromal tumor is an infrequent tumor of the gastrointestinal tract with very rare involvement of the
esophagus. We present a case of a patient with dysphagia and a 4 cm submucosal mass. The patient underwent thoracoscopic
enucleation with complete resection of the mass. We present case details and operative video highlighting the important
surgical steps of exposure and retraction. We believe that the Endoloop is a very useful tool in providing countertraction
needed during minimally invasive resection of such lesions.
INTRODUCTION
A gastrointestinal stromal tumor (GIST) is the most common
sarcoma that arises in the GI tract, although its occurrence is rare
with a reported incidence at approximately seven cases per mil-
lion [1]. Studies have also shown GIST to be a result of a gain-of-
function mutation in c-KIT with positive immunohistochemical
staining for CD34 and, the more specific marker, CD117 [2]. This
immunophenotype suggests that GISTs are derived from inter-
stitial cells of Cajal, and originate in the stomach (50–60%), small
intestine (25–30%), colon/rectum (1–2%), with ∼1% originating
in the esophagus [3]. Due to its rarity, optimal management of
esophageal GIST remains to be delineated.
CASE REPORT
The patient is a 67-year-old male with a history of atrial fibril-
lation and hyperlipidemia who presented with several months
of dysphagia to solids. The endoscopic evaluation revealed a
∼4 × 2.3 cm submucosal lesion arising from the muscularis
propria in the distal esophagus (Fig. 1). The lesion was 2 cm prox-
imal to the GE junction and intermittently disappearing with
peristaltic contractions. The lesion was biopsied and showed
low-grade GIST with 1–3 mitoses per high power field and was
CD 117 positive. Computerized tomography (CT) scan showed a
right esophageal mass without evidence of local invasion (Fig. 2).
After discussing risks and benefits with the patient and
obtaining informed consent, the decision was made to proceed
with surgical resection. An upper endoscopy was performed
confirming the findings seen before. The patient was intubated
with a dual lumen endotracheal tube and placed in a left lat-
eral decubitus position. Standard video-assisted thoracoscopic
ports were placed. The inferior pulmonary ligament was divided
allowing the lung to be reflected away. Approximately ∼4 cm
lesion was visualized in the distal esophagus. Using an endo-
scopic harmonic scalpel, the pleura was incised and adhesions
to the right lower lobe were dissected.
The lesion was carefully dissected away from the surround-
ing muscular layers of the esophagus. An anchoring suture was
first placed at the superior pole of the mass as an attempt to
provide countertraction, which failed due to the fragility of the
lesion. Countertraction was better achieved with an Endoloop
Ligature (Ethicon Inc, New Brunswick, NJ) placed around the
basal portion of the lesion. Care was taken to gently pull on the
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Figure 1: Esophagogastroduodenoscopy showed an esophageal prominence 2 cm above the GE junction with endoscopic ultrasound confirming 39.8 × 23.2 mm mass.
Figure 2: Computerized tomography (CT) demonstrated a right distal esophageal
mass.
Endoloop without overtly tightening it and inadvertently cutting
through the lesion. The mass was then completely enucleated
and separated from the esophageal mucosal layer. The highly
vascular tumor was prone to intermittent bleeding and was
controlled with a combination of pressure and Bovie electro-
cautery. The specimen was removed through a laparoscopic
specimen bag. The esophageal muscle layer was reapproximated
with interrupted sutures. Repeat upper endoscopy confirmed
the integrity of the esophageal mucosal layer. The patient under-
went an esophagogram on post-operative day one prior to oral
intake and discharged home later that day. Final pathology con-
firmed a 4.7 cm esophageal GIST with <5 mitoses per high power
field and positive for CD 117 and 34.
DISCUSSION
A total of 76% of patients with esophageal GIST are symp-
tomatic at the time of diagnosis, most commonly presenting
with dysphagia, weight loss, hemoptysis, abdominal pain,
nausea, cough, vomiting, gastroesophageal reflux and night
sweats [4]. Visualization of GIST can be achieved through
endoscopy, but definitive diagnosis before considering a resec-
tion can sometimes be difficult. While 18F-fluorodeoxyglucose
positron emission tomography has been used to describe
the malignancy of GIST, results cannot discriminate the
tumor from other benign masses in the esophagus [5]. Simi-
larly, esophageal ultrasound and CT scans cannot make this
distinction either. The only effective method of distinguishing
esophageal GIST from other mesenchymal tumors is ultrasound-
guided fine-needle aspiration biopsy, which allows for his-
tologic examination of the tumor and immunohistochemical
staining.
The current standard of care for treatment of GIST is surgical
resection with the aim to achieve negative tumor margins.
Studies have shown that adjuvant therapy with tyrosine kinase
inhibitors can improve recurrence-free survival in localized GIST.
Unfortunately, these studies did not include esophageal GIST,
thus Imatinib therapy needs to be further explored with this
subtype [6]. Although currently experimental, it is important
to consider neoadjuvant therapy with pre-operative Imatinib
when treating a large esophageal GIST, as the reduction in
tumor size caused by tyrosine kinase inhibitors may decrease the
risk of tumor rupture and optimize resection [7]. Patients with
high-risk features should be considered for adjuvant Imatinib
therapy.
Surgical options for esophageal GIST include minimally
invasive vs open esophagectomy or enucleation based on tumor
size and location. Enucleation is preferred for patients with
comorbidities and with small tumor size while esophagectomy
is indicated for larger tumor sizes. Zheng et al. [8] reported
the effectiveness of using Endoloop assistance in endoscopic
enucleation of deep GIST gastric tumors. We believe that it
should be considered as a useful adjunct for countertraction
in video-assisted enucleation of esophageal GIST lesions. Gentle
and stable traction provided by the Endoloop can aid in better
visualization of the tissue planes between the esophageal
mucosa, lesion, and the muscle layer and help in quicker and
safer completion of the case. The use of Endoloop for retraction
has been reported in other minimally invasive surgeries [9]. It has
the advantage of the ease of use and low risk of instrumental
perforation during retraction. The other advantage of Endoloop
is their relatively low-cost compared to other retraction devices
and small diameter making their use through the same
port with other instruments possible; however, instrumental
positioning and re-positioning can be difficult with Endoloop
[9] and it requires obtaining a circumferential plane around
the retracted structure. Recently, Funamizu et al. [10] reported
a series demonstrating the efficacity and safety of Endoloop
use in gallbladder retraction in single-incision laparoscopic
cholecystectomy.
In conclusion, esophageal GISTs are very uncommon and are
amenable to thoracoscopic enucleation. This allows for lower
morbidity with an overnight hospital stay and a quick return to
normal activities. The use of Endoloop for countertraction pro-
vides excellent exposure of the underlying esophageal muscle
and mucosal layers.
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